Crossmark

Cannabidiol (CBD) as a novel treatment in the early phases of psychosis

Crossref DOI link: https://doi.org/10.1007/s00213-021-05905-9

Published Online: 2021-07-13

Published Print: 2022-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chesney, Edward https://orcid.org/0000-0003-2851-5252
Oliver, Dominic

McGuire, Philip
License Information

Text and Data Mining valid from 2021-07-13

Version of Record valid from 2021-07-13
More Information

Article History

Received: 6 January 2021

Accepted: 15 June 2021

First Online: 13 July 2021

Declarations

:

: The authors declare no competing interests.